Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(8.2%),Morgan Stanley Investment Management Inc.(7.6%)
Royalty Pharma | 10-Q: Q3 2024 Earnings Report
Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS THIRD QUARTER 2024 RESULTS
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A
Royalty Pharma | 8-K: Current report
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Coyne Terrance P.
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lloyd George W.
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Urist Marshall
Royalty Pharma | 10-Q: Q2 2024 Earnings Report
Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS SECOND QUARTER 2024 RESULTS
Royalty Pharma | 8-K: Current report
Royalty Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-R & H Trust Co. (Guernsey) Limited(9.2%),Achille G. Severgnini(9.2%), etc.
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A
Royalty Pharma | 8-K: Current report
Royalty Pharma | 8-K: Current report
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Norden Gregory
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director LOVE TED W
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director HODGSON DAVID C
No Data
No Data